ebomi
Colour theme
Sign in
Insider · CIK 0001465837

Boxer Capital, LLC

CIK 0001465837 Name as filed on the most recent filing

Filed as Boxer Capital, LLC (49)

117 transaction lines · from 49 filings · filed 2009-07-29 to 2023-10-17 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

16 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2021-03-05 S, Open-market sale Mirati Therapeutics, Inc.MRTX 181, disposed Open Form 4 filing 0000899243-21-010812
2020-12-30 P, Open-market purchase Odonate Therapeutics, Inc.ODT 1,746,380, acquired Open Form 4 filing 0000899243-20-035535
2020-12-28 P, Open-market purchase Odonate Therapeutics, Inc.ODT 2 lines 5,117,048, acquired Open Form 4 filing 0000899243-20-035535
2020-10-30 S, Open-market sale Mirati Therapeutics, Inc.MRTX 2 lines 80,800,000, disposed Open Form 4 filing 0000899243-20-030060
2020-09-29 P, Open-market purchase Odonate Therapeutics, Inc.ODT 1,717,760, acquired Open Form 4 filing 0000899243-20-026512
2020-09-28 P, Open-market purchase Odonate Therapeutics, Inc.ODT 1,214,396, acquired Open Form 4 filing 0000899243-20-026512
2020-09-25 P, Open-market purchase PMV Pharmaceuticals, Inc.PMVP 17,100,000, acquired Open Form 4 filing 0001209191-20-052341
2020-09-09 P, Open-market purchase Odonate Therapeutics, Inc.ODT 1,232,720, acquired Open Form 4 filing 0000899243-20-024780
2020-09-08 P, Open-market purchase Odonate Therapeutics, Inc.ODT 276,172, acquired Open Form 4 filing 0000899243-20-024780
2020-09-04 P, Open-market purchase Odonate Therapeutics, Inc.ODT 1,862,739, acquired Open Form 4 filing 0000899243-20-024780
2020-08-28 P, Open-market purchase Odonate Therapeutics, Inc.ODT 20,000,003, acquired Open Form 4 filing 0000899243-20-023768
2020-07-28 P, Open-market purchase iTeos Therapeutics, Inc.ITOS 2 lines 27,075,000, acquired Open Form 4 filing 0000899243-20-020687
2020-07-21 P, Open-market purchase Pandion Therapeutics, Inc.PAND 12,999,996, acquired Open Form 4 filing 0000899243-20-019894
2020-01-10 P, Open-market purchase Mirati Therapeutics, Inc.MRTX 4,875,000, acquired Open Form 4 filing 0000899243-20-001161
2019-07-17 S, Open-market sale Mirati Therapeutics, Inc.MRTX 2 lines 71,268,328, disposed Open Form 4 filing 0000899243-19-019989
2019-06-26 P, Open-market purchase Odonate Therapeutics, Inc.ODT 9,999,990, acquired Open Form 4 filing 0000899243-19-018537
2019-03-28 S, Open-market sale Solid Biosciences Inc.SLDB 571,800, disposed Open Form 4 filing 0000899243-19-009195
2019-03-27 S, Open-market sale Solid Biosciences Inc.SLDB 1,104,000, disposed Open Form 4 filing 0000899243-19-009195
2019-03-26 S, Open-market sale Solid Biosciences Inc.SLDB 2,772,000, disposed Open Form 4 filing 0000899243-19-009195
2019-03-01 S, Open-market sale Mirati Therapeutics, Inc.MRTX 29,325,000, disposed Open Form 4 filing 0000899243-19-006352
2019-01-17 P, Open-market purchase Mirati Therapeutics, Inc.MRTX 9,300,000, acquired Open Form 4 filing 0000899243-19-001646
2019-01-09 S, Open-market sale Mirati Therapeutics, Inc.MRTX 3 lines 7,732,100, disposed Open Form 4 filing 0000899243-19-000909
2019-01-08 S, Open-market sale Mirati Therapeutics, Inc.MRTX 4 lines 28,657,072, disposed Open Form 4 filing 0000899243-19-000909
2018-12-26 P, Open-market purchase Odonate Therapeutics, Inc.ODT 311,815, acquired Open Form 4 filing 0000899243-18-031845
2018-12-21 P, Open-market purchase Odonate Therapeutics, Inc.ODT 2 lines 1,347,015, acquired Open Form 4 filing 0000899243-18-031845
2018-11-05 S, Open-market sale Esperion Therapeutics, Inc.ESPR 6 lines 3,429,843, disposed Open Form 4 filing 0000899243-18-028245
2018-11-02 S, Open-market sale Esperion Therapeutics, Inc.ESPR 2 lines 2,208,500, disposed Open Form 4 filing 0000899243-18-028245
2018-10-24 P, Open-market purchase Odonate Therapeutics, Inc.ODT 394,753, acquired Open Form 4 filing 0000899243-18-027532
2018-06-07 P, Open-market purchase Mirati Therapeutics, Inc.MRTX 7,499,993, acquired Open Form 4 filing 0000899243-18-016029
2018-03-26 P, Open-market purchase Odonate Therapeutics, Inc.ODT 754,097, acquired Open Form 4 filing 0000899243-18-008514
2018-03-23 P, Open-market purchase Odonate Therapeutics, Inc.ODT 1,028,914, acquired Open Form 4 filing 0000899243-18-008514
2018-03-22 P, Open-market purchase Odonate Therapeutics, Inc.ODT 490,143, acquired Open Form 4 filing 0000899243-18-008514
2017-12-06 P, Open-market purchase Odonate Therapeutics, Inc.ODT 9,999,984, acquired Open Form 4 filing 0000899243-17-028261
2017-11-16 P, Open-market purchase Mirati Therapeutics, Inc.MRTX 3,318,432, acquired Open Form 4 filing 0000899243-17-026986

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 3
  • Open-market sale 13
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Boxer Capital, LLC, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001465837

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.